Insider Transactions in Q2 2021 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.97 P/Share
|
|
Apr 20
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.13%
|
$45
$3.02 P/Share
|
|
Apr 20
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.02 P/Share
|
|
Apr 20
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.02 P/Share
|
|
Apr 20
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$315
$3.02 P/Share
|
|
Apr 19
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.13%
|
$45
$3.04 P/Share
|
|
Apr 19
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.04 P/Share
|
|
Apr 19
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.04 P/Share
|
|
Apr 19
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$315
$3.04 P/Share
|
|
Apr 16
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.13%
|
$45
$3.03 P/Share
|
|
Apr 16
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.03 P/Share
|
|
Apr 16
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.03 P/Share
|
|
Apr 16
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$315
$3.03 P/Share
|